A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Silk Road Medical Traded its First Shares this Morning on Nasdaq: (SILK)

What To Know

  • Stroke is one of the most catastrophic, debilitating and costly conditions worldwide, and the company believes the best way to mitigate the mortality, morbidity and cost burden of strokes is to prevent them in the first place.
  • Erica has a unique leadership style – she does a cartwheel every day and has built an engaging and successful business culture based on the behaviors and mindset needed to do a cartwheel, such as core strength, flexibility and courage.

April 4, 2019

Silk Road Medical traded its first shares this morning on Nasdaq: (SILK).

Silk Road Medical is focused on reducing the risk of stroke by treating carotid artery disease, a condition that affects more than 4 million people in the U.S. and is estimated to be the primary cause of up to one-third of strokes. Stroke is one of the most catastrophic, debilitating and costly conditions worldwide, and the company believes the best way to mitigate the mortality, morbidity and cost burden of strokes is to prevent them in the first place. Clinical evidence has demonstrated that with proper diagnosis and treatment, stroke due to carotid artery disease is mostly preventable.

The company has pioneered an entirely new, minimally invasive procedure – TransCarotid Artery Revascularization, or TCAR – to treat carotid artery disease. TCAR has the potential to become the standard of care, and Silk Road Medical is the only player in the TCAR market with products having transcarotid FDA labeling.

TCAR addresses an unmet clinical need because the current treatment options have reported higher risks of stroke or procedure-related adverse events. Becoming a publicly traded company will help expand commercialization efforts and increase adoption of TCAR using the company’s products, improve reimbursement for TCAR, and enable development of additional products to treat other vascular disease states.

Erica Rogers, who has been at the helm of Silk Road Medical as president and CEO since 2012, rang today’s NASDAQ Closing Bell in celebration of today’s IPO. Erica has a unique leadership style – she does a cartwheel every day and has built an engaging and successful business culture based on the behaviors and mindset needed to do a cartwheel, such as core strength, flexibility and courage. Rumor has it she may even perform one of her legendary cartwheels at the Closing Bell Ceremony.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The study is designed to assess the clinical utility and workflow benefits of Swoop® system images acquired at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients receiving amyloid-targeting therapy at the times specified in the labeling (before the fifth, seventh, and fourteenth infusions).
“Tom and I have more than 50 years of experience,” Harp adds. “The decision to found Polymer Medical was done after careful consideration of the landscape and market opportunity; we will raise the level of competition and quality for customers.” Polymer Medical is located in a newly refurbished plant is at 168 Thorn Ave., Orchard Park, N.Y.
The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.
Details of the session: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.
SABIC advises the project was initiated together with the dialysis department at Jessa Hospital, one of the largest non-university medical cluster in the Limburg region of Flanders, Belgium.

By using this website you agree to accept Medical Device News Magazine Privacy Policy